Dose conversion to IPX066 in advanced Parkinson's disease patients treated with carbidopa-levodopa-entacapone

被引：0
|
作者：
Hsu, A.
Khanna, S.
Kell, S.
Espay, A.
Gil, R.
Singer, C.
Gupta, S.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
416
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [31] Long-Term Safety of IPX066 Extended-Release Carbidopa-Levodopa Capsules in Patients with Motor Fluctuations in Advanced Parkinson's Disease
    Ellenbogen, Aaron
    Nausieda, Paul
    Pourcher, Emmanuelle
    Rudzinska, Monika
    Kell, Sherron
    O'Connell, Martin
    Hsu, Ann
    Gupta, Suneel
    NEUROLOGY, 2013, 80
  • [32] The Influence of Concomitant Medications on the Efficacy of IPX066 in Advanced Parkinson's Disease
    LeWitt, Peter A.
    Metman, Leo Verhagen
    Rubens, Robert
    Khanna, Sarita
    Kell, Sherron
    Gupta, Suneel
    ANNALS OF NEUROLOGY, 2015, 78 : S53 - S53
  • [33] Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (Stalevo®)
    Hsu, Ann
    Yao, Hsuan-Ming
    Gupta, Suneel
    Modi, Nishit B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (09): : 995 - 1003
  • [34] COST-EFFECTIVENESS ANALYSIS OF IPX066 IN ADVANCED PARKINSON'S DISEASE
    Arnold, R. J.
    Frasco, M. A.
    Layton, A.
    Rustay, N. R.
    Chen, S.
    VALUE IN HEALTH, 2015, 18 (03) : S283 - S283
  • [35] Onset and Duration of Clinical Effect of IPX066 in Advanced Parkinson's Disease
    Ellenbogen, Aaron
    Hauser, Robert A.
    Modi, Nishit B.
    Hsu, Ann
    Khanna, Sarita
    Gupta, Suneel
    ANNALS OF NEUROLOGY, 2015, 78 : S48 - S48
  • [36] Long-Term Safety of IPX066 Extended-Release Carbidopa-Levodopa Capsules in Patients with Early Parkinson's Disease
    Nausieda, Paul
    Rudzinska, Monika
    Kell, Sherron
    O'Connell, Martin
    Hsu, Ann
    Gupta, Suneel
    NEUROLOGY, 2013, 80
  • [37] Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis
    LeWitt, Peter A.
    Metman, Leo Verhagen
    Rubens, Robert
    Khanna, Sarita
    Kell, Sherron
    Gupta, Suneel
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (02) : 47 - 55
  • [38] IPX066, a mixed immediate/sustained-release levodopa preparation for Parkinson's disease
    Ondo, William
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (14) : 2081 - 2085
  • [39] Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone
    Park, Jongkyu
    Kim, Younsoo
    Youn, Jinyoung
    Lee, Phil H.
    Sohn, Young H.
    Koh, Seoung B.
    Lee, Jee-Young
    Baik, Jong S.
    Cho, Jin W.
    NEUROLOGY INDIA, 2017, 65 (04) : 746 - 751
  • [40] Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease
    Delea, Thomas E.
    Thomas, Simu K.
    Hagiwara, May
    Mancione, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1543 - 1552
12345